Gregory Verdine

Har­vard's Gre­go­ry Ver­dine has big am­bi­tions for his minipro­tein 'braces' — and now $107M to guide them to the clin­ic

Har­vard sci­en­tist Gre­go­ry Ver­dine’s mis­sion has al­ways been clear: drug the un­drug­gable. He’s now one step clos­er, with $107 mil­lion in the bank to bring …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.